Quantum Genomics SA (PA:ALQGC) — Stock Price
Quantum Genomics SA (PA:ALQGC) is currently trading at €0.07 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.07 and €0.07. This page tracks Quantum Genomics SA's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ALQGC company net worth.
Quantum Genomics SA (ALQGC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Quantum Genomics SA's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Quantum Genomics SA Income Statement — Revenue, Profit & Earnings by Year
Quantum Genomics SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €10.00 | €19.80K | €2.52 Million | €3.14 Million | €1.83 Million |
| Cost of Revenue | €1.15 Million | €1.44 Million | €29.50 Million | €20.34 Million | €16.73 Million |
| Gross Profit | €-1.15 Million | €-1.42 Million | €-26.99 Million | €-17.21 Million | €-14.90 Million |
| Research & Development | — | — | — | — | — |
| SG&A | €324.90K | €1.60 Million | €2.95 Million | €16.71 Million | €12.30 Million |
| Total Operating Expenses | €327.53K | €1.72 Million | €479.95K | €2.91 Million | €1.93 Million |
| Operating Income | €-1.47 Million | €-3.14 Million | €-30.08 Million | €-20.11 Million | €-16.83 Million |
| EBITDA | €-1.47 Million | €-2.87 Million | €-30.20 Million | €-19.41 Million | €-14.67 Million |
| EBIT | €-1.47 Million | €-3.14 Million | €-30.46 Million | €-19.80 Million | €-14.81 Million |
| Interest Expense | €27.53K | €21.40K | €17.67K | €46.00K | €1.46 Million |
| Income Before Tax | €-8.89 Million | €-3.21 Million | €-27.48 Million | €-19.85 Million | €-18.29 Million |
| Income Tax Expense | — | €-34.43K | €-2.55 Million | €-2.49 Million | €-2.07 Million |
| Net Income | €-8.89 Million | €-3.17 Million | €-24.94 Million | €-17.36 Million | €-16.22 Million |
Quantum Genomics SA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Quantum Genomics SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €354.65K | €3.75 Million | €23.66 Million | €21.24 Million | €32.80 Million |
| Total Current Assets | €353.10K | €3.69 Million | €23.39 Million | €20.23 Million | €31.83 Million |
| Cash & Equivalents | €0.00 | €0.00 | €0.00 | €5.01 Million | €5.00 Million |
| Short-term Investments | — | €-11.00K | €32.31K | €257.00K | €285.00K |
| Net Receivables | €27.44K | €119.18K | €12.90 Million | €696.00K | €3.85 Million |
| Inventory | — | €-119.18K | €-12.90 Million | €1.14 Million | €1.75 Million |
| Property, Plant & Equipment | €1.05K | €7.89K | €22.95K | €30.16K | €26.54K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €2.81 Million | €3.31 Million | €20.05 Million | €11.57 Million | €8.15 Million |
| Total Current Liabilities | €171.95K | €1.35 Million | €17.59 Million | €7.87 Million | €7.27 Million |
| Long-term Debt | €2.13 Million | €2.72 Million | €3.03 Million | €3.00 Million | €1.87K |
| Net Debt | €2.34 Million | €-830.55K | €-7.37 Million | €-10.09 Million | €-26.27 Million |
| Total Stockholder Equity | €-2.46 Million | €436.66K | €3.61 Million | €9.67 Million | €24.65 Million |
| Retained Earnings | €-9.85 Million | €-28.11 Million | €-24.93 Million | €-16.56 Million | €-11.54 Million |
Quantum Genomics SA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Quantum Genomics SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-20.21 Million | €-17.02 Million | €-11.99 Million | €-10.43 Million | €-10.90 Million |
| Capital Expenditures | €32.54K | €45.00K | €411.00K | €116.00K | €16.00K |
| Free Cash Flow | €-20.21 Million | €-17.06 Million | €-12.40 Million | €-10.54 Million | €-10.92 Million |
| Investing Cash Flow | €-152.54K | €-45.00K | €-411.00K | €-116.00K | €-231.00K |
| Financing Cash Flow | €17.21 Million | €3.46 Million | €28.39 Million | €6.91 Million | €14.84 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | €1.57 Million | €1.48 Million | €859.00K | — |
| Depreciation | €263.77K | €390.00K | €137.00K | €153.00K | €19.02K |
| Change in Cash | €-3.15 Million | €-13.60 Million | €24.96 Million | €-3.63 Million | €3.71 Million |
Quantum Genomics SA Earnings History — EPS Actual vs. Analyst Estimates
Track Quantum Genomics SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 28, 2026 | — | — | — |
| Feb 25, 2026 | 0.00 | 0.00 | — |
| Dec 03, 2025 | 0.00 | 0.00 | — |
| Sep 03, 2025 | 0.00 | 0.00 | — |
| Apr 30, 2025 | -0.01 | 0.00 | — |
| Mar 11, 2025 | — | — | — |
| Nov 27, 2024 | 0.00 | 0.00 | — |
| Aug 28, 2024 | 0.00 | 0.00 | — |